Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
DOCS

Dr. Martens plc

DOCSLSEUnited KingdomConsumer CyclicalFootwear & AccessoriesFTSE 250

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in…more

P/E32.80xP/B1.74xROIC8.2%Dividend yield3.9%
£627.90M
Market Cap
EV: £840.74M
MOM4
QUAL3
VAL8
RSK3
DOCS
£627.90M
Market Cap · EV £840.74M

Dr. Martens plc

MOM4
QUAL3
VAL8
RSK3

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in…more

Latest RNS from Dr. Martens plc

All DOCS news → · RNS daily feed

Analyst consensus: Hold

As of 10 Nov 2026, 6 analysts rate Dr. Martens plc a Hold, with 50% buy ratings and a mean price target of 95p (range 60p–141p), +46% vs the current price.

Strong buy: 0Buy: 3Hold: 2Sell: 0Strong sell: 1

Full analyst history →

More Consumer Cyclical companies